Glaukos Corporation GKOS
$129.48
▲ +2.05% 24H
About
Glaukos Corporation is a medical technology company dedicated to the development and commercialization of innovative products for the treatment of glaucoma, corneal disorders, and retinal diseases. Its primary function is to address the substantial unmet medical needs present in ophthalmic healthcare. Glaukos is partic…
SectorHealthcare
ExchangeNYSE
IndustryMedical Devices
CountryUnited States
Employees995
TickerGKOS
Statistics
Market Cap$7.56B
Revenue (TTM)$507.4M
Net Income-$187.7M
Net Margin-37.0%
EPS$-3.28
P/E-37.87
P/S13.02
P/B10.63
EV/EBITDA-163.76
ROE-26.4%
Dividend Yield—
Price$129.48
Data: Twelve Data · Revenue = mcap / P/S